Crinetics Pharmaceuticals, Inc. (CRNX) — SC 13G/A Filings
All SC 13G/A filings from Crinetics Pharmaceuticals, Inc.. Browse 12 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (12)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Oct 17, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Wellington Management Amends Crinetics Pharma Stake
— Feb 8, 2024 Risk: low
Wellington Management Group LLP, a major investment firm, filed an amended SC 13G/A on February 8, 2024, indicating its ownership of Crinetics Pharmaceuticals, -
BlackRock Maintains Significant Stake in Crinetics Pharma
— Jan 25, 2024
BlackRock, Inc. filed an amended SC 13G/A on January 25, 2024, disclosing its ownership of Crinetics Pharmaceuticals, Inc. common stock as of December 31, 2023.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX